TickerFactsScreenerDevelopers

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2000: $02001: $68.0K2002: $53.0K2003: $21.0K2004: -$31.0K2005: $704.0K2006: -$1.82M2007: -$2.43M2008: -$2.08M2009: -$1.74M2010: -$459.0K2011: $1.49M2012: $3.98M2013: $2.74M2014: $6.67M2015: $14.13M2016: $9.90M2017: $5.88M2018: $5.02M2019: -$12.22M2020: $35.46M2021: $19.34M2022: -$3.02M2023: -$4.86M2024: -$7.76M2025: -$9.98M-$9.98M
2000Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$9.98M-28.6%
2024-$7.76M-59.8%
2023-$4.86M-61.1%
2022-$3.02M-115.6%
2021$19.34M-45.5%
2020$35.46M+390.1%
2019-$12.22M-343.7%
2018$5.02M-14.7%
2017$5.88M-40.6%
2016$9.90M-29.9%
2015$14.13M+111.7%
2014$6.67M+143.7%
2013$2.74M-31.2%
2012$3.98M+167.6%
2011$1.49M+424.2%
2010-$459.0K+73.7%
2009-$1.74M+16.0%
2008-$2.08M+14.5%
2007-$2.43M-33.7%
2006-$1.82M-358.0%
2005$704.0K+2371.0%
2004-$31.0K-247.6%
2003$21.0K-60.4%
2002$53.0K-22.1%
2001$68.0K—
2000$0—